Latest / Stock Movers / Generac Roars, AutoNation Sinks, Ultragenyx Jumps on New FDA Approval
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data.
- 0:16Speaker 2: It is time now for a look at some of
- 0:18Speaker 2: the stocks on the move today. And for that, we
- 0:21Speaker 2: are joined by Bloomberg News equities reporter Arvaliz Bonilla-Ramos here
- 0:25Speaker 2: in our Bloomberg Interactive Broker Studio. You brought us some
- 0:29Speaker 2: morsels today. Generac is on the move.
- 0:32Speaker 1: Absolutely.
- 0:33Speaker 3: Yeah. Thanks so much for having me always. I brought
- 0:36Speaker 3: a couple of like bigger moves that happened during the day.
- 0:39Speaker 3: Just a little bit of size and scope for y'all.
- 0:41Speaker 3: So Generic Holdings, that sticker GNRC, that's a backup power
- 0:45Speaker 3: generator company known for homes generators. But they're really doing
- 0:49Speaker 3: a push to be a part of the booming data
- 0:51Speaker 3: center growth. And what's happening there, they closed up nearly
- 0:55Speaker 3: 18 percent today. That intraday move was the highest since 2021.
- 1:01Speaker 3: And that is also an 80% jump from the stocks
- 1:05Speaker 3: closing yesterday, Wednesday. All this also happened after they agreed
- 1:09Speaker 3: to supply a billion worth of generators for Amazon's data center.
- 1:14Speaker 3: And they're going to be doing this, I believe, the
- 1:18Speaker 3: first supplies can be happening next year, 2027, 2028. It
- 1:22Speaker 3: was a draw for me when I got my latest
- 1:25Speaker 3: apartment in my new lady's house.
- 1:26Speaker 1: The Generac was there.
- 1:27Speaker 2: And I was like, this is fantastic. Yeah. So it's
- 1:31Speaker 2: a lifesaver. But for those data companies, too, I mean,
- 1:34Speaker 2: they need the power. And we're having to find different
- 1:37Speaker 2: ways to do this.
- 1:38Speaker 3: Yeah, and this is a company that's been doing this
- 1:40Speaker 3: at a home level, but now it's sort of like
- 1:43Speaker 3: doing that little switch for them. And this is a
- 1:46Speaker 3: really big deal contract for them as well. And Amazon
- 1:49Speaker 3: is really at the forefront of the push for data centers, too.
- 1:53Speaker 2: How about AutoNation? Because I'm looking at their shares.
- 1:56Speaker 3: They were lower.
- 1:56Speaker 2: Yeah.
- 1:57Speaker 3: They were lower. Their shares ended down, I believe, 10%
- 2:00Speaker 3: or roughly 10% today. The ticker is AN. And this happened,
- 2:05Speaker 3: the Morgan Stanley Laguna Conference has been going on for
- 2:08Speaker 3: a couple of days. A lot of companies have been
- 2:11Speaker 3: sort of like working the room, but they said something
- 2:16Speaker 3: very specifically on how consumers are spending. Basically, consumers, quote unquote,
- 2:22Speaker 3: spend very nicely, but when it comes to spending big capital...
- 2:25Speaker 3: they're sort of like putting a stop and this means
- 2:28Speaker 3: you know uh automations products specifically yeah why are they
- 2:32Speaker 3: putting a stop just like being more discretionary like i
- 2:35Speaker 3: don't want to spend the big money so i'm good
- 2:37Speaker 3: with just like spending every day making maybe going out
- 2:40Speaker 3: um but maybe like big buys or just uh double
- 2:43Speaker 3: thinking about yeah for sure.
- 2:45Speaker 2: Right all right now you brought us something in the
- 2:48Speaker 2: uh is this biospace space is this what ultra gen
- 2:50Speaker 2: x pharma is.
- 2:51Speaker 3: All about yeah biotechnology Okay, and they have a cool
- 2:54Speaker 3: ticker symbol.
- 2:55Speaker 1: It's rare.
- 2:56Speaker 2: R-A-R-E. Tell us about what's going on there.
- 2:59Speaker 3: Sure, absolutely. Shares of the biotech company advanced roughly 13% today.
- 3:05Speaker 3: The firm got FDA approval for its gene therapy to treat...
- 3:10Speaker 3: pediatric patients that have a rare inherited disease that progressively
- 3:16Speaker 3: damages the brain and nervous system. I had to read
- 3:18Speaker 3: that because I want to make sure that we know
- 3:20Speaker 3: exactly what they're doing. It's rare what they do, but
- 3:24Speaker 3: maybe not. So it's pediatric.
- 3:25Speaker 2: It's for kids.
- 3:26Speaker 3: It's for kids, yeah. It's worth noting that Sherzo Aviona
- 3:30Speaker 3: Therapeutic also went up or climbed with this announcement, and
- 3:36Speaker 3: it's because... Rare, actually, Ultragenyx had bought global rights to
- 3:42Speaker 3: the gene therapy from Abiona in 2012.
- 3:47Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:51Speaker 1: us throughout the day for the latest roundup of companies
- 3:54Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:58Speaker 1: listen to Bloomberg Radio live. Catch us on YouTube, Bloomberg.com,
- 4:03Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 4:06Speaker 1: Business app.